JP2021500400A5 - - Google Patents
Info
- Publication number
- JP2021500400A5 JP2021500400A5 JP2020542534A JP2020542534A JP2021500400A5 JP 2021500400 A5 JP2021500400 A5 JP 2021500400A5 JP 2020542534 A JP2020542534 A JP 2020542534A JP 2020542534 A JP2020542534 A JP 2020542534A JP 2021500400 A5 JP2021500400 A5 JP 2021500400A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762573933P | 2017-10-18 | 2017-10-18 | |
| US62/573,933 | 2017-10-18 | ||
| PCT/US2018/056138 WO2019079339A1 (en) | 2017-10-18 | 2018-10-16 | COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTIVIRAL THERAPY |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021500400A JP2021500400A (ja) | 2021-01-07 |
| JPWO2019079339A5 JPWO2019079339A5 (https=) | 2023-02-03 |
| JP2021500400A5 true JP2021500400A5 (https=) | 2023-02-03 |
| JP7466907B2 JP7466907B2 (ja) | 2024-04-15 |
Family
ID=66173467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542534A Active JP7466907B2 (ja) | 2017-10-18 | 2018-10-16 | 広域スペクトルの抗ウイルス治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12213955B2 (https=) |
| EP (1) | EP3697404B1 (https=) |
| JP (1) | JP7466907B2 (https=) |
| CN (1) | CN111886008B (https=) |
| TW (1) | TWI860281B (https=) |
| WO (1) | WO2019079339A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018089306A1 (en) | 2016-11-10 | 2018-05-17 | Oyagen, Inc. | Methods of treating and inhibiting ebola virus infection |
| CN112789925B (zh) * | 2019-06-27 | 2023-06-02 | Oppo广东移动通信有限公司 | 用于指示空间关系信息的方法和设备 |
| US11738025B2 (en) | 2020-02-04 | 2023-08-29 | Oyagen, Inc. | Method for treating coronavirus infections |
| AU2021235899A1 (en) * | 2020-03-08 | 2022-10-13 | Humanigen, Inc. | Methods for treating coronavirus infection and resulting inflammation-induced lung injury |
| US11628165B1 (en) * | 2020-03-25 | 2023-04-18 | Helen Feng | Method of boosting immune system against viral infection |
| ES2862462B2 (es) * | 2020-04-06 | 2023-04-27 | Servicio Andaluz De Salud | Compuestos para la profilaxis y/o el tratamiento del sindrome de dificultad respiratoria aguda |
| WO2021211738A1 (en) * | 2020-04-15 | 2021-10-21 | Sanford Burnham Prebys Medical Discovery Institute | Methods and compositions for antiviral treatment |
| WO2021226479A1 (en) * | 2020-05-07 | 2021-11-11 | The Regents Of The University Of California | Inhaled statins for treatment of viral respiratory diseases |
| BR112022023746A2 (pt) * | 2020-05-22 | 2023-02-07 | Alberto Riveros Carlos | Sistema, método e uso de um determinado medicamento para reduzir a replicação viral na mucosa das vias aéreas |
| WO2021249240A1 (zh) * | 2020-06-11 | 2021-12-16 | 养生堂有限公司 | Palovarotene在抗hbv病毒治疗中的用途 |
| US20240131036A1 (en) * | 2020-07-02 | 2024-04-25 | The Uab Research Foundation | Compositions and methods of treating conditions |
| CN112390731B (zh) * | 2020-11-16 | 2022-11-25 | 成都大学 | 一种具有多靶点的维甲酸类衍生物及其制备方法与应用 |
| US11998562B2 (en) | 2021-01-25 | 2024-06-04 | University Of South Florida | Ophthalmological formulations for the prevention of a coronavirus infection |
| CN117062611A (zh) | 2021-01-26 | 2023-11-14 | 惠和生物技术(上海)有限公司 | 嵌合抗原受体（car）构建体和表达car构建体的nk细胞 |
| US20220378727A1 (en) * | 2021-05-14 | 2022-12-01 | The University Of Hong Kong | Dry powder formulations of tamibarotene for pulmonary and intranasal delivery |
| CN116891497B (zh) * | 2022-04-02 | 2025-12-16 | 上海旭成医药科技有限公司 | 视黄酸受体激动剂、其制备方法、中间体、药物组合物和应用 |
| WO2023210634A1 (ja) * | 2022-04-28 | 2023-11-02 | 国立大学法人東海国立大学機構 | 拡張障害を伴う心不全の治療用医薬組成物 |
| CN119454680B (zh) * | 2024-12-06 | 2025-06-17 | 华南农业大学 | 贝沙罗汀在制备抗prrsv或治疗猪蓝耳病的药物中的应用 |
| CN121177272A (zh) * | 2025-11-10 | 2025-12-23 | 北京市农林科学院 | 化合物am580在预防或治疗塞内卡病毒病中的用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7341717B2 (en) | 2001-04-13 | 2008-03-11 | Gpc Biotech Ag | Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor |
| US20060151574A1 (en) * | 2002-11-29 | 2006-07-13 | Gpc Biotech Ag | Formulations useful against hepatitis C virus infections |
| WO2005120479A1 (en) * | 2004-06-09 | 2005-12-22 | Gpc Biotech Ag | Use of selenium or a selenium salt and a retinoid acid or a retinoid in the treatment of viral hepatitis c |
| EP1886685A1 (en) | 2006-08-11 | 2008-02-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| ES2609825T3 (es) * | 2007-01-18 | 2017-04-24 | Evolva Sa | 1,3-Dioxanos sustituidos útiles como moduladores de PPAR |
| CN104662036B (zh) * | 2012-04-25 | 2018-11-09 | 华辉安健（北京）生物科技有限公司 | 乙肝肝炎病毒功能性受体的组成以及相关应用 |
| US20150290235A1 (en) * | 2012-11-23 | 2015-10-15 | Ab Science | Use of small molecule inhibitors/activators in combination with (deoxy)nucleoside or (deoxy)nucleotide analogs for treatment of cancer and hematological malignancies or viral infections |
| KR20160113302A (ko) | 2014-02-18 | 2016-09-28 | 칠드런＇스 하스피틀 로스 앤젤레스 | 호중구감소증을 치료하기 위한 조성물 및 방법 |
| CA2942469C (en) * | 2014-03-10 | 2024-06-11 | Cornell University | Combination therapy for head and neck cancer |
| WO2018054891A1 (en) | 2016-09-20 | 2018-03-29 | Ruprecht-Karls-Universität | Compounds and combinations thereof for preventing and/or treating hbv and/or hdv infections |
-
2018
- 2018-10-16 WO PCT/US2018/056138 patent/WO2019079339A1/en not_active Ceased
- 2018-10-16 US US16/757,312 patent/US12213955B2/en active Active
- 2018-10-16 CN CN201880080271.9A patent/CN111886008B/zh active Active
- 2018-10-16 EP EP18867413.9A patent/EP3697404B1/en active Active
- 2018-10-16 JP JP2020542534A patent/JP7466907B2/ja active Active
- 2018-10-17 TW TW107136527A patent/TWI860281B/zh active